Editorial
Accepted on 11 Feb 2025
Editorial: Hematopoietic Stress in Stem Cell Homeostasis and Disease Pathogenesis
Frontiers in Hematology
doi 10.3389/frhem.2025.1571674
Volumes
8 Publications
Review
Accepted on 10 Feb 2025
Abnormalities of the primary and secondary hemostasis in multiple myeloma: insights from studies on thrombopoiesis, coagulation system, and bone marrow microenvironment
Frontiers in Hematology
doi 10.3389/frhem.2025.1435193
Mini Review
Published on 07 Feb 2025
The aging hematopoietic stem cell niche: a mini review
Frontiers in Hematology
doi 10.3389/frhem.2025.1525132
- 172 views
Case Report
Accepted on 04 Feb 2025
Acquired von Willebrand Disease associated with Smoldering Multiple Myeloma and Hereditary Hemorrhagic Telangiectasia successfully treated with Daratumumab, Pomalidomide, and Dexamethasone: Hitting three birds with one stone?case report
Frontiers in Hematology
doi 10.3389/frhem.2025.1499500
Original Research
Accepted on 04 Feb 2025
FACIT-Fatigue Scale in Patients with Cold Agglutinin Disease: Psychometric Validation and Estimation of Clinically Meaningful Change
Frontiers in Hematology
doi 10.3389/frhem.2025.1490130
Original Research
Accepted on 04 Feb 2025
Time to Initiation of Antiresorptive Agents in Multiple Myeloma to Reduce Skeletal Related Events
Frontiers in Hematology
doi 10.3389/frhem.2025.1521017
Mini Review
Accepted on 03 Feb 2025
The role of Glucocorticoids in Erythropoiesis
Frontiers in Hematology
doi 10.3389/frhem.2025.1540152
Editorial
Published on 24 Jan 2025
Editorial: Two decades of targeted therapies in hematology: new targets and novel combinations
Frontiers in Hematology
doi 10.3389/frhem.2025.1548984
- 259 views